Glaxosmithkline Plc (GSK) Shareholder Grantham Mayo Van Otterloo & Co LLC Has Lifted Its Position by $7.85 Million

GlaxoSmithKline plc (NYSE:GSK) Logo

Grantham Mayo Van Otterloo & Co Llc increased its stake in Glaxosmithkline Plc (GSK) by 12.99% based on its latest 2018Q2 regulatory filing with the SEC. Grantham Mayo Van Otterloo & Co Llc bought 196,300 shares as the company’s stock declined 4.33% while stock markets rallied. The institutional investor held 1.71 million shares of the major pharmaceuticals company at the end of 2018Q2, valued at $68.81M, up from 1.51 million at the end of the previous reported quarter. Grantham Mayo Van Otterloo & Co Llc who had been investing in Glaxosmithkline Plc for a number of months, seems to be bullish on the $90.52 billion market cap company. The stock decreased 0.32% or $0.12 during the last trading session, reaching $37.3. About 6.20 million shares traded or 111.21% up from the average. GlaxoSmithKline plc (NYSE:GSK) has declined 2.50% since December 8, 2017 and is downtrending. It has underperformed by 18.12% the S&P500.

Grantham Mayo Van Otterloo & Co Llc, which manages about $14.08B US Long portfolio, decreased its stake in Oracle Corp (NYSE:ORCL) by 2.50M shares to 12.76M shares, valued at $562.40 million in 2018Q2, according to the filing. It also reduced its holding in Mcdonalds Corp (NYSE:MCD) by 224,600 shares in the quarter, leaving it with 11,400 shares, and cut its stake in New Oriental Ed & Tech Grp I (NYSE:EDU).

More notable recent GlaxoSmithKline plc (NYSE:GSK) news were published by: Investorplace.com which released: “3 Big Stock Charts for Tuesday: Morgan Stanley, Ross Stores and Dominion Energy – Investorplace.com” on December 04, 2018, also Fool.com with their article: “Here’s Why Agenus Stock Popped 51.6% in November – The Motley Fool” published on December 06, 2018, Seekingalpha.com published: “Glaxo sells five consumer brands to Crown Labs – Seeking Alpha” on November 30, 2018. More interesting news about GlaxoSmithKline plc (NYSE:GSK) were released by: Benzinga.com and their article: “GlaxoSmithKline (NYSE:GSK) Strikes $5B M&A Deal With Tesaro (NASDAQ:TSRO) In Quest To Boost Oncology Franchise – Benzinga” published on December 03, 2018 as well as Fool.com‘s news article titled: “Better Buy: AbbVie Inc. vs. GlaxoSmithKline PLC – Motley Fool” with publication date: November 13, 2018.

GlaxoSmithKline plc (NYSE:GSK) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.